Aventisub LLC
Records under this name other than the patents Aventisub LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,899,419 | Package with Break-Away Clamshell Formerly held In force · High confidence | In force | High confidence | |
| US 8,919,559 | Package with Break-Away Clamshell Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,130,620 | Liquid pharmaceutical composition for oral administration comprising fexofenadine Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 6,794,410 | Use of (Z) -2-Cyano-3-Hydroxy-BUT-2-Enoic ACID-(4' -Trifluoromethylphenyl)-Amide for Treating Multiple Sclerosis Term ended Term ended Sep 26, 2026 · High confidence | Term ended | Term ended Sep 26, 2026 | High confidence |
| US 7,618,650 | Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof Term ended Ended no later than Aug 16, 2026 · From the USPTO record | Term ended | Ended no later than Aug 16, 2026 | From the USPTO record |
| US 7,402,672 | Substituted 1H-PYRROLO[3,2-B, 3,2-C, and 2,3-C]PYRIDINE-2-Carboxamides and Related Analogs as Inhibitors of Casein Kinase Lepsilon Term ended Term ended Apr 12, 2026 · High confidence | Term ended | Term ended Apr 12, 2026 | High confidence |
| US 7,625,889 | Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists Term ended Term ended Feb 10, 2026 · From the USPTO record | Term ended | Term ended Feb 10, 2026 | From the USPTO record |
| US 7,923,466 | 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I Term ended Term ended Feb 3, 2026 · From the USPTO record | Term ended | Term ended Feb 3, 2026 | From the USPTO record |
| US 7,629,376 | 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I Term ended Term ended Jan 24, 2026 · From the USPTO record | Term ended | Term ended Jan 24, 2026 | From the USPTO record |
| US 7,538,106 | Application of 2-Cyano-10- (2-Methyl-3- (METHYLAMINO)- Propyl) Phenothiazine or a Pharmaceutically Acceptable Salt as Medicament Term ended Term ended Nov 21, 2025 · High confidence | Term ended | Term ended Nov 21, 2025 | High confidence |